NineDiagnostics.xyz – Namecheap customer – (United States)
Builders across industries use .xyz domains to present new technologies and ideas online. Quantum computing startup QMatter.xyz aims to reduce complex problems for drug discovery and beyond. Energy technology company Superheat.xyz develops compute-powered thermal systems for homes and businesses. Solar technology company Arinna.xyz introduces ultrathin solar for space applications. In this week’s #WebsiteWednesday, we’ll introduce you to a biotechnology company developing AI-enabled nanosensor technology for functional precision medicine: NineDiagnostics.xyz.
NineDiagnostics.xyz is the online home of Nine Diagnostics, a biotechnology company developing what it describes as “AI-enabled nanosensor technology” for functional precision medicine. According to the website, the company’s platform is designed to determine treatment effectiveness and discover new biology by analyzing molecular patterns from blood samples, with potential applications in oncology and drug development. In June 2026, the company announced it has been selected for the Damon Runyon Cancer Research Foundation’s InVEST Program, which the foundation describes as providing “a $50,000 investment to support any new company started by Damon Runyon alumni or current Clinical Investigators or Rachleff-Innovators.”
The website explores Nine Diagnostics’ approach to functional precision medicine through its AI-enabled nanosensor platform. According to the company, the technology combines carbon nanotube nanosensors with machine learning to analyze molecular signatures in blood samples, aiming to measure treatment effectiveness and identify new biomarkers. Visitors can also browse the Publications section, which highlights peer-reviewed research covering nanosensor development, biomarker discovery, and related advances in cancer diagnostics. One featured study, published in peer-reviewed journal Nature Nanotechnology, describes a machine learning-enabled liquid biopsy platform that identified and classified brain tumors from blood samples while helping researchers uncover biological signatures associated with disease.1
The Team page introduces the scientists and advisors behind Nine Diagnostics: co-founders Freddy T. Nguyen, MD, PhD, Daniel A. Heller, PhD, and Mijin Kim, PhD, alongside a group of scientific and operational advisors. Dr. Nguyen serves as CEO, Dr. Heller as Chief Scientific Officer, and Dr. Kim serves as Scientific Advisor. According to the MIT Institute for Medical Engineering and Science, Dr. Nguyen is a physician-scientist with a background in chemistry, engineering, and clinical pathology. He serves as a Research Fellow at the MIT Office of Innovation and Director of the MIT Catalyst Scholars Program, and was selected as a 2025 Scholar in Diagnostic Excellence by the National Academy of Medicine, one of 11 individuals nationwide chosen for the program.2 3 As stated on Memorial Sloan Kettering Cancer Center’s website, Dr. Heller is a member of its Molecular Pharmacology Program and leads the Cancer Nanomedicine Laboratory, which focuses on nanotechnologies for cancer diagnosis and treatment.4 According to Georgia Institute of Technology’s School of Chemistry and Biochemistry, Dr. Kim is an Assistant Professor whose research is focused on developing nanosensor technology for cancer research and early disease detection.5 Dr. Kim has also been named a STAT Wunderkind and an MIT Technology Review Innovator Under 35 for her nanosensor cancer detection research.
Nine Diagnostics brings notable credentials to its work: selection for the Damon Runyon Cancer Research Foundation’s InVEST Program, alongside a founding and advisory team with ties to Memorial Sloan Kettering Cancer Center and the Georgia Institute of Technology. The company’s technology spans nanotechnology, machine learning, and molecular diagnostics, disciplines that intersect and evolve together. That range makes NineDiagnostics.xyz a fitting online home: the .xyz domain’s broad, general-purpose nature is designed to grow alongside a company like Nine Diagnostics, whose work may expand into new scientific areas over time. It also places Nine Diagnostics among a growing base of deep tech and startup ventures that have adopted .xyz. We look forward to seeing how Nine Diagnostics’ research develops in the years ahead. You can learn more by following Nine Diagnostics on X/Twitter, LinkedIn, Instagram, and Facebook, and by visiting NineDiagnostics.xyz.
1. https://www.nature.com/articles/s41565-025-02080-2
2. https://nam.edu/news-and-insights/national-academy-of-medicine-names-11-scholars-in-diagnostic-excellence-for-2025/
3. https://imes.mit.edu/news-events/dr-freddy-nguyen-selected-2025-scholar-diagnostic-excellence-national-academy-medicine
4. https://www.mskcc.org/research/ski/labs/daniel-heller
5. https://chemistry.gatech.edu/people/mijin-kim
XYZ is proud to share about the many incredible members that make up the XYZ community! We encourage you to do your own research before using the products and services of the websites we feature. The information about products and services contained in this blog post does not constitute endorsement or recommendation by XYZ.
